Zobrazeno 1 - 10
of 23
pro vyhledávání: '"James R. Woodworth"'
Autor:
Howard Trachtman, James R Woodworth, Frank S. Czerwiec, Krishna Padmanabhan, Leslie Johnson, Hiddo J.L. Heerspink, Youssef M K Farag, Debbie S. Gipson, Caitlin Cornwall, Xin-Ru Pan-Zhou, Liron Walsh, John F. Reilly, Katherine R. Tuttle, Gregory A Gaich
Publikováno v:
Kidney International Reports
Kidney International Reports, 6(10), 2575-2584. ELSEVIER SCIENCE INC
Kidney International Reports, 6(10), 2575-2584. ELSEVIER SCIENCE INC
Introduction A critical unmet need exists for precision therapies for chronic kidney disease. GFB-887 is a podocyte-targeting, small molecule inhibitor of transient receptor potential canonical-5 (TRPC5) designed specifically to treat patients with g
Autor:
James R. Woodworth, Michael L. Zeckel
This chapter seeks to provide an overview of clinically useful information regarding the pharmacokinetics, clinical uses, and safety profile of vancomycin. Vancomycin exhibits poor oral bioavailability. Following oral administration, only trace amoun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ca6168a610d58c03cc3b2b7d2217507
https://doi.org/10.1201/9781003067269-9
https://doi.org/10.1201/9781003067269-9
Publikováno v:
Diabetes Technology & Therapeutics. 6:147-153
A model was established allowing prediction of blood glucose response from glucose clamp results performed in healthy volunteers. Data from published studies performed in healthy volunteers were used to establish, test, and validate a model for the e
Autor:
Ronald R. Bowsher, Ronald E. Chance, William E. Legan, James R. Woodworth, Renee A. Lynch, Patricia Brown-Augsburger, Paula F. Santa
Publikováno v:
Clinical Chemistry. 45:104-110
Insulin lispro is an insulin analog in which the primary sequence has been altered by the inversion of amino acids B28 and B29. To date, it has not been possible to specifically measure insulin lispro in the presence of endogenous insulin because of
Autor:
Stephanie A. Amiel, Stonny E. Joseph, David Hopkins, Mark L. Evans, James R. Woodworth, Jonathan M Janes, Anna Korzon-Burakowska
Publikováno v:
Diabetes Care. 21:2098-2102
OBJECTIVE To assess the effect of mixing the insulin analog lispro (Humalog) with NPH (Humulin I) before injection on lispro's fast, short action profile. RESEARCH DESIGN AND METHODS A total of 12 healthy volunteers received subcutaneous abdominal in
Autor:
Joyce Downing-Shelton, Ronald R. Bowsher, Rocco L. Brunelle, Paula F. Santa, Daniel C. Howey, Howard Rowe, James R. Woodworth
Publikováno v:
Clinical Pharmacology & Therapeutics. 58:459-469
Background [Lys(B28), Pro(B29)]-human insulin (lispro) is an insulin analogue with a reduced capacity for self-association and faster absorption from subcutaneous injection sites. We hypothesized that administration of lispro closer to a meal would r
Autor:
Howard Rowe, Benito J. Cerimele, Rocco L. Brunelle, Joyce A. Compton, James R. Woodworth, Daniel C. Howey, Ronald R. Bowsher
Publikováno v:
Diabetes Care. 17:366-371
OBJECTIVE To compare and contrast the pharmacokinetics and glucodynamics of two insulin mixtures, one of 50% NPH human insulin and 50% Regular human insulin (50/50) and one of 70% NPH human insulin and 30% Regular human insulin (70/30), in healthy ma
Publikováno v:
Diabetes. 43:396-402
[Lys(B28, Pro(B29)]-human insulin (LYSPRO) is an insulin analogue in which the natural amino acid sequence of the B-chain at positions 28 and 29 is inverted. These changes result in an insulin molecule with a greatly reduced capacity for self-associa
Publikováno v:
Diabetes Care. 17:64-69
OBJECTIVE To provide distinct definitions and quantify the establishment of onset, peak, and duration of action for insulins. RESEARCH DESIGN AND METHODS We administered single subcutaneous doses of 10 U regular insulin to 10 volunteer subjects and 2
Publikováno v:
Journal of Antimicrobial Chemotherapy. 33:655-659